4 260

Cited 48 times in

Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.

Authors
Oh, YT; Kim, CH; Choi, JH; Kang, SH; Chun, M
Citation
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 72(1):79-82, 2004
Journal Title
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN
0167-81401879-0887
Abstract
Sensory neural hearing loss (SNHL) was evaluated in the patients who were treated with concurrent chemoradiation therapy for nasopharyngeal carcinoma. Ten from 48 ears showed persistent SNHL. Radiotherapy techniques, radiation dose to inner ear and post-treatment otitis media were significant predicting factors for SNHL.
MeSH terms
AdultCarcinoma/*drug therapy/*radiotherapyCisplatin/*adverse effects/therapeutic useCombined Modality TherapyFemaleHearing Loss, Sensorineural/*epidemiology/*etiologyHumansIncidenceMaleMiddle AgedNasopharyngeal Neoplasms/*drug therapy/*radiotherapyProspective StudiesRadiation Injuries/*physiopathology
DOI
10.1016/j.radonc.2004.02.009
PMID
15236878
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiation Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Otolaryngology
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
AJOU Authors
오, 영택김, 철호최, 진혁강, 승희전, 미선
Full Text Link
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse